PRESS RELEASE published on 12/04/2025 at 15:48, 2 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses 3.57% stake in Spire Healthcare Group plc as per Form 8.3 filing Form 8.3 Disclosure Vanguard Group Stake Spire Healthcare Group
PRESS RELEASE published on 12/04/2025 at 15:47, 2 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Alphawave IP Group plc The Vanguard Group, Inc. discloses a 1.81% stake in Alphawave IP Group plc. Additional disclosures related to Qualcomm Incorporated Disclosure The Vanguard Group Stake Qualcomm Alphawave IP Group Plc
PRESS RELEASE published on 12/04/2025 at 15:46, 2 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc The Vanguard Group, Inc. discloses holding 5.51% stake in Dowlais Group plc. Dealings disclosed include purchase of 255,665 securities at 0.85 GBP per unit Securities The Vanguard Group Dealings Stake Dowlais Group Plc
PRESS RELEASE published on 12/04/2025 at 15:45, 2 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Empiric Student Property plc The Vanguard Group, Inc. discloses a 1.87% stake in Empiric Student Property plc as of 03 Dec 2025, with recent securities purchases and sales Securities Dealings Vanguard Group Financial Disclosure Stake Disclosure Empiric Student Property Plc
PRESS RELEASE published on 12/04/2025 at 15:44, 2 months 17 days ago Custodian Property Income REIT plc: Share Buyback Custodian Property Income REIT plc announces share buyback of 150,000 ordinary shares at 81.0 pence per share. Company aims for strong income return with a diversified UK property portfolio Share Buyback Custodian Property Income REIT Plc Diversified Portfolio Income Return UK Properties
PRESS RELEASE published on 12/04/2025 at 15:44, 2 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Petershill Partners plc The Vanguard Group, Inc. discloses 1.11% stake in Petershill Partners plc with 11,970,739 shares. Form 8.3 filing on 04-Dec-2025 Form 8.3 The Vanguard Group Shareholding Stake Disclosure Petershill Partners Plc
PRESS RELEASE published on 12/04/2025 at 15:42, 2 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc The Vanguard Group, Inc. discloses 1.67% position in Bakkavor Group plc. Details on interests and short positions presented in Form 8.3 Securities Form 8.3 Disclosure Vanguard Group Bakkavor Group
PRESS RELEASE published on 12/04/2025 at 15:41, 2 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses 5.38% ownership in Just Group plc's 10p ordinary shares as of 03 Dec 2025. Purchases and sales details included Shares Vanguard Group Ownership Disclosure Purchases And Sales Just Group Plc
PRESS RELEASE published on 12/04/2025 at 15:40, 2 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc The Vanguard Group, Inc. discloses a 1.23% ownership in International Personal Finance plc. Dealings include purchasing 49,951 and selling 12,150 10p ordinary securities Securities Dealings The Vanguard Group Ownership Disclosure 10p Ordinary International Personal Finance Plc
PRESS RELEASE published on 12/04/2025 at 15:38, 2 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group, Inc. discloses a 4.89% stake in NCC Group plc. Details on positions, dealing disclosures, and other information provided in Form 8.3 The Vanguard Group Financial Disclosure Form 8.3 Disclosure Stock Holdings NCC Group Plc
Published on 02/21/2026 at 00:45, 1 day 6 hours ago Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 1 day 6 hours ago Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:00, 1 day 8 hours ago Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 1 day 9 hours ago Organto Foods Completes Warrant Exercise Incentive Program
Published on 02/21/2026 at 12:00, 19 hours 22 minutes ago Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Published on 02/21/2026 at 12:00, 19 hours 22 minutes ago Abivax présente, au Congrès de l’ECCO 2026, les premières preuves d’une activité antifibrotique d'obefazimod, ainsi que de nouvelles analyses de son efficacité et de sécurité dans les MICI
Published on 02/20/2026 at 18:36, 1 day 12 hours ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 1 day 12 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 19:29, 1 day 11 hours ago SFPI GROUP: bilan du contrat de liquidité S2 S025
